Yi, S., Su, L., Li, B., Li, Z., Jin, Z., Jiang, M., Yu, W., Li, Z., Luo, J., Yang, W., Li, F., Wang, C., Wu, H., Wang, Q., Yu, B., Chen, J., Xu, J., Qiu, L. (2025). A phase I study of HDM2005, a ROR1 targeted antibody-drug conjugate (ADC), in patients with relapsed or refractory B-cell non-Hodgkin lymphoma (B-NHL) or classical Hodgkin lymphoma(cHL). Blood. https://doi.org/10.1182/blood-2025-1808